Showing results (271-280 of 312) with videos related to
Sort By:
Pageof 32
Archives of Internal Medicine|May 13, 2009
ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analysesJackson T Wright, Jeffrey L Probstfield, William C Cushman, et al.Clinical Nephrology|December 1, 2016
Association between chronic kidney disease and cancer mortality: A report from the ALLHATDhruti P Chen, Barry R Davis, Lara M Simpson, et al.Diabetes Care|March 6, 2014
Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trialKaren L Margolis, Patrick J O'Connor, Timothy M Morgan, et al.Hypertension (Dallas, Tex. : 1979)|June 29, 2022
Blood Pressure Intervention and Control in SPRINTWilliam C Cushman, Robert J Ringer, Carlos J Rodriguez, et al.Hypertension (Dallas, Tex. : 1979)|March 14, 2018
Blood Pressure Measurement in SPRINT (Systolic Blood Pressure Intervention Trial)Karen C Johnson, Paul K Whelton, William C Cushman, et al.American Journal of Hypertension|April 1, 1996
Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research GroupB R Davis, J A Cutler, D J Gordon, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|December 4, 2002
Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)William C Cushman, Charles E Ford, Jeffrey A Cutler, et al.Circulation. Cardiovascular Quality and Outcomes|March 8, 2012
Long-term effects of incident diabetes mellitus on cardiovascular outcomes in people treated for hypertension: the ALLHAT Diabetes Extension StudyJoshua I Barzilay, Barry R Davis, Sara L Pressel, et al.BMJ (Clinical Research Ed.)|January 12, 2010
The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD studyDenise E Bonds, Michael E Miller, Richard M Bergenstal, et al.The New England Journal of Medicine|March 16, 2010
Effects of intensive blood-pressure control in type 2 diabetes mellitus, William C Cushman, Gregory W Evans, et al.Pageof 32